Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250)

Sam Chun Dang Pharm. Revenue

Sam Chun Dang Pharm. had revenue of 64.87B KRW in the quarter ending March 31, 2026, with 28.15% growth. This brings the company's revenue in the last twelve months to 246.05B, up 15.47% year-over-year. In the year 2025, Sam Chun Dang Pharm. had annual revenue of 231.81B with 9.90% growth.

• Revenue (ttm): 246.05B
• Revenue Growth: +15.47%
• P/S Ratio: 24.72
• Revenue / Employee: 583.07M
• Employees: 422
• Market Cap: 6.08T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	231.81B	20.88B	9.90%
Dec 31, 2024	210.92B	18.26B	9.47%
Dec 31, 2023	192.67B	15.33B	8.65%
Dec 31, 2022	177.34B	10.06B	6.01%
Dec 31, 2021	167.27B	412.57M	0.25%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 12, 2026

Data Sources Report a data error